Race Oncology: The tip of the spear in the race to beat cancer 

Listen to ASX-listed Race Oncology Managing Director Phillip Lynch talk to Matt Birney on the Bulls N’ Bears Report about Race Oncology’s cancer-fighting biotechnology that has been trialing well and is about to be put to the test again.

Race Oncology: The tip of the spear in the race to beat cancer 
Listen to ASX-listed Race Oncology Managing Director Phillip Lynch talk to Matt Birney on the Bulls N&rsquo; Bears Report about Race Oncology&rsquo;s cancer-fighting biotechnology that has been trialing well and is about to be put to the test again.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement